Ginkgo Bioworks stock trailed the S&P 500 on July 26, 2025, despite a market uptick, while operating within the broader medical and biomedical industries.
1 report, 1 independent
Updated Jul 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Ginkgo Bioworks stock trailed the S&P 500 on July 26, 2025, despite a market uptick, while operating within the broader medical and biomedical industries.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Ginkgo Bioworks
American biotechnology company
Nothing else this week.
Coverage
Newest first; wire copies grouped- ZacksGinkgo Bioworks Holdings, Inc. (DNA) Stock Falls Amid Market Uptick: What Investors Need to Know In the latest close session, Ginkgo Bioworks Holdings, Inc. (DNA) was down 6.31% at $13.96. The stock